BASF SE (XTRA:BAS) agreed to acquire ASL on October 28, 2020. The transaction covers all assets, including seed production, intellectual property rights, germplasm, research and development facilities as well as staff. The transfer it is planned to close the acquisition on January 1, 2023.

BASF SE (XTRA:BAS) completed the acquisition of ASL on January 3, 2023.